You are here

Help eliminate barriers to cost with the Janssen CarePath Savings Program for INVOKAMET® XR and INVOKAMET® (canagliflozin/metformin HCl)

Preferred coverage* for most commercial and Medicare Part D patients


INVOKANA® Cost Support & Janssen CarePath

INVOKANA® pricing and CarePath™

The Savings Card is not available to patients enrolled in federally subsidized healthcare programs that cover prescription drugs, including Medicare, Medicaid, TRICARE, or other federal or state programs.

INVOKANA® Cost Support & Janssen CarePath

Help your patients with a free 30-day trial offer



*Coverage that makes brand-name medications available at a lower co-payment than Tier 3 brand-name drugs. Tier 1 medications are usually generics with low co-payments.

Data on file. Janssen Pharmaceuticals, Inc. MMIT as of April 8, 2016. Commercial and Medicare detail exports.

If your patients are currently uninsured

Johnson & Johnson Patient Assistance Foundation, Inc. (JJPAF) is committed to providing access to uninsured individuals who lack the financial resources to pay for their medicines. If your patient needs INVOKAMET® XR or INVOKAMET® and is uninsured and unable to pay for their medicine, please have them contact a JJPAF program specialist at 1-800-652-6227, 9:00 am–6:00 pm, or visit the Foundation Web site at JJPAF.org to see if they might qualify for assistance.

If your patients have questions about affording their medication, a comprehensive list of additional programs is available at JanssenPrescriptionAssistance.com/INVOKANA.

Learn about COVERAGE AND ACCESS